Severe acute respiratory syndrome (SARS) is an acute infectious disease of the respiratory
system. Although a novel coronavirus has been identified as the causative agent of SARS …

Background and purpose Severe acute respiratory syndrome (SARS) is a highly
transmissible disease with significant morbidity and mortality. Death from SARS is most often …

Severe acute respiratory syndrome (SARS) is a recently emerged infectious disease caused
by a novel coronavirus, but its immunopathological mechanisms have not yet been fully …

Objective and background: Pathological changes in severe acute respiratory syndrome
(SARS) suggest that SARS sequelae are associated with dysregulation of cytokine and …

Fourteen cytokines or chemokines were analyzed on 88 RT‐PCR‐confirmed severe acute
respiratory syndrome (SARS) patients. IFN‐γ, IL‐18, TGF‐β, IL‐6, IP‐10, MCP‐1, MIG, and IL …

Rationale: There is currently no optimal treatment or effective drug for severe acute
respiratory syndrome (SARS), because the immunopathologic mechanism is poorly …

Severe acute respiratory syndrome (SARS) has spread to a global pandemic, especially in
Asia. The transmission route of SARS has been clarified, but the immunopathogenesis of …

In a cohort of 38 patients with severe acute respiratory syndrome (SARS), we observed
leukopenia in 47% of patients, lymphopenia in 84%, and T lymphopenia in 95%. CD4+ T …

Severe acute respiratory syndrome (SARS) is a new disease which has spread rapidly and
widely. We wished to know whether evaluation of in vitro cytokine production could …

This report demonstrates that a rapid decrease of peripheral T cell subsets is a unique
characteristic in patients with SARS during acute infection, although total white blood cell …